Patents Assigned to CMS Peptides Patent Holding Company Limited
  • Biologically active peptides and their new uses
    Patent number: 8703695
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: April 22, 2014
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptides and their new uses
    Patent number: 8658592
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: February 25, 2014
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptides and their new uses
    Patent number: 8586525
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: November 19, 2013
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • NOVEL BIOLOGICALLY ACTIVE PEPTIDES AND THEIR NEW USES
    Publication number: 20130190241
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Application
    Filed: February 21, 2013
    Publication date: July 25, 2013
    Applicant: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming WONG, Kong LAM
  • NOVEL BIOLOGICALLY ACTIVE PEPTIDES AND THEIR NEW USES
    Publication number: 20130190255
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Application
    Filed: February 21, 2013
    Publication date: July 25, 2013
    Applicant: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming WONG, Kong LAM
  • Novel Biologically Active Peptides and their New Uses
    Publication number: 20120171234
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Application
    Filed: March 7, 2012
    Publication date: July 5, 2012
    Applicant: CMS PEPTIDES PATENT HOLDING COMPANY LIMITED
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptide PTTKTYFPHF
    Patent number: 7718768
    Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced therefrom are also disclosed.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: May 18, 2010
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
    Patent number: 7718764
    Abstract: Peptides derived from the peptide CMS-010, which has the formula VAPEEHPTLLTEAPLNPK, are disclosed with their use as pharmaceutical compositions. A method is also disclosed for making a pharmaceutical composition comprising providing a peptide derived from CMS-010 and mixing said peptide with a pharmaceutical acceptable carrier.
    Type: Grant
    Filed: April 25, 2005
    Date of Patent: May 18, 2010
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL)
    Patent number: 7696152
    Abstract: A substantially pure and biologically active peptides consisting of tyrosyl-seryl-leucine (YSL) is disclosed. Nucleic acids that have sequences coding for the biologically active peptide and pharmaceutical formulation produced therefrom are also disclosed.
    Type: Grant
    Filed: July 31, 2006
    Date of Patent: April 13, 2010
    Assignee: CMS Peptides Patent Holdings Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptide comprising tyrosyl-seryl-valine (YSV)
    Patent number: 7666986
    Abstract: The tripeptide Tyrosyl-seryl-valine is disclosed with its use as a nutritional supplement. A method of making a nutritional supplement comprising obtaining the tripeptide Tyrosyl-seryl-valine and mixing the tripeptide with a biologically or therapeutically acceptable carrier is also disclosed.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: February 23, 2010
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Compositions comprising the biologically active peptide YSL
    Patent number: 7491689
    Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced thereform are also disclosed.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: February 17, 2009
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptide comprising Tyrosyl-seryl-valine(YSV)
    Patent number: 7427599
    Abstract: The tripeptide Tyrosyl-seryl-valine is disclosed with its use as a pharmaceutical composition in treating a condition whose effects can be reduced by stimulating T-cell transformation and a cell proliferative disorder. A method is also disclosed making a pharmaceutical composition comprising providing the tripeptide Tyrosyl-seryl-valine and mixing said tripeptide with a pharmaceutical acceptable carrier.
    Type: Grant
    Filed: June 22, 2004
    Date of Patent: September 23, 2008
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptides
    Patent number: 7402653
    Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced thereform are also disclosed.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: July 22, 2008
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptides comprising Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (IVTNTT)
    Patent number: 7396817
    Abstract: The peptide Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (SEQ ID NO.1) is disclosed with its use as a pharmaceutical composition in reducing symptoms of viral disease and stimulating properties of immune system in a subject. A method is also disclosed for making a pharmaceutical composition comprising providing an Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (SEQ ID NO.1) peptide and mixing said peptide with a pharmaceutical acceptable carrier.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: July 8, 2008
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam